These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 3496229)

  • 1. MPP+ (1-methyl-4-phenylpyridine) is a neurotoxin to dopamine-, norepinephrine- and serotonin-containing neurons.
    Namura I; Douillet P; Sun CJ; Pert A; Cohen RM; Chiueh CC
    Eur J Pharmacol; 1987 Apr; 136(1):31-7. PubMed ID: 3496229
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serotonergic conversion of MPTP and dopaminergic accumulation of MPP+.
    Shen RS; Abell CW; Gessner W; Brossi A
    FEBS Lett; 1985 Sep; 189(2):225-30. PubMed ID: 3876242
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 1-Methyl-4-phenylpyridine (MPP+): regional dopamine neuron uptake, toxicity, and novel rotational behavior following dopamine receptor proliferation.
    Altar CA; Heikkila RE; Manzino L; Marien MR
    Eur J Pharmacol; 1986 Nov; 131(2-3):199-209. PubMed ID: 3493157
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of MPTP and its pyridinium metabolites on monoamine uptake and on central catecholamine neurons in mice.
    Jonsson G; Nwanze E; Luthman J; Sundström E
    Acta Physiol Scand; 1986 Oct; 128(2):187-94. PubMed ID: 3535380
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Histochemistry of MPTP oxidation in the rat brain: sites of synthesis of the parkinsonism-inducing toxin MPP+.
    Nakamura S; Vincent SR
    Neurosci Lett; 1986 Apr; 65(3):321-5. PubMed ID: 3487052
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective retention of MPP+ within the monoaminergic systems of the primate brain following MPTP administration: an in vivo autoradiographic study.
    Herkenham M; Little MD; Bankiewicz K; Yang SC; Markey SP; Johannessen JN
    Neuroscience; 1991; 40(1):133-58. PubMed ID: 2052148
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative toxicity of MPTP, MPP+ and 3,3-dimethyl-MPDP+ to dopaminergic neurons of the rat substantia nigra.
    Sayre LM; Arora PK; Iacofano LA; Harik SI
    Eur J Pharmacol; 1986 May; 124(1-2):171-4. PubMed ID: 3487462
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 1-methyl-4-phenylpyridine is neurotoxic to the nigrostriatal dopamine pathway.
    Bradbury AJ; Costall B; Domeney AM; Jenner P; Kelly ME; Marsden CD; Naylor RJ
    Nature; 1986 Jan 2-8; 319(6048):56-7. PubMed ID: 3484542
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Central depletion of dopamine in rats by 1-methyl-4-phenylpyridine.
    Okada M; Yokotani K; Yamashita M; Ikeda H; Osumi Y
    Life Sci; 1989; 45(5):391-9. PubMed ID: 2788790
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurotoxic damage to the nigrostriatal system in rats following intranigral administration of MPDP+ and MPP+.
    Sun CJ; Johannessen JN; Gessner W; Namura I; Singhaniyom W; Brossi A; Chiueh CC
    J Neural Transm; 1988; 74(2):75-86. PubMed ID: 3266233
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The neurotoxin 1-methyl-4-phenylpyridinium is sequestered within neurons that contain the vesicular monoamine transporter.
    Speciale SG; Liang CL; Sonsalla PK; Edwards RH; German DC
    Neuroscience; 1998 Jun; 84(4):1177-85. PubMed ID: 9578404
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 1-Methyl-4-phenylpyridine (MPP+) is toxic to mesencephalic dopamine neurons in culture.
    Mytilineou C; Cohen G; Heikkila RE
    Neurosci Lett; 1985 Jun; 57(1):19-24. PubMed ID: 3875812
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selectivity of the parkinsonian neurotoxin MPTP: toxic metabolite MPP+ binds to neuromelanin.
    D'Amato RJ; Lipman ZP; Snyder SH
    Science; 1986 Feb; 231(4741):987-9. PubMed ID: 3080808
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure-neurotoxicity trends of analogues of 1-methyl-4-phenylpyridinium (MPP+), the cytotoxic metabolite of the dopaminergic neurotoxin MPTP.
    Arora PK; Riachi NJ; Fiedler GC; Singh MP; Abdallah F; Harik SI; Sayre LM
    Life Sci; 1990; 46(5):379-90. PubMed ID: 2304377
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methyl-4-phenylpyridinium (MPP+) differentially affects monoamine release and re-uptake in murine embryonic stem cell-derived dopaminergic and serotonergic neurons.
    Martí Y; Matthaeus F; Lau T; Schloss P
    Mol Cell Neurosci; 2017 Sep; 83():37-45. PubMed ID: 28673772
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Uptake inhibition protects nigro-striatal dopamine neurons from the neurotoxicity of 1-methyl-4-phenylpyridine (MPP+) in mice.
    Sundström E; Goldstein M; Jonsson G
    Eur J Pharmacol; 1986 Nov; 131(2-3):289-92. PubMed ID: 3493159
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dopamine-releasing action of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and 1-methyl-4-phenylpyridine (MPP+) in the neostriatum of the rat as demonstrated in vivo by the push-pull perfusion technique: dependence on sodium but not calcium ions.
    Sirinathsinghji DJ; Heavens RP; McBride CS
    Brain Res; 1988 Mar; 443(1-2):101-16. PubMed ID: 3258784
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) reduces dopamine and serotonin but accelerates norepinephrine metabolism in the rat brain. Effect of chronic pretreatment with MPTP.
    Enz A; Hefti F; Frick W
    Eur J Pharmacol; 1984 May; 101(1-2):37-44. PubMed ID: 6086364
    [TBL] [Abstract][Full Text] [Related]  

  • 19. N-methyl-4-phenylpyridine (MMP+) together with 6-hydroxydopamine or dopamine stimulates Ca2+ release from mitochondria.
    Frei B; Richter C
    FEBS Lett; 1986 Mar; 198(1):99-102. PubMed ID: 3082673
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Active uptake of MPP+, a metabolite of MPTP, by brain synaptosomes.
    Chiba K; Trevor AJ; Castagnoli N
    Biochem Biophys Res Commun; 1985 May; 128(3):1228-32. PubMed ID: 3873939
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.